Handouts are available online at:
https://www.ariconference.com/webinars/hendren.pdf
Certificates of participation are available upon successful completion of a brief knowledge quiz:
https://www.classmarker.com/online-test/start/?quiz=hav530dfdd9ca1a3
Robert L. Hendren, D.O., is Professor of Psychiatry and Behavioral Science; Director of Child and Adolescent Psychiatry; Director of the Autism and Neurodevelopment Program, Co-Director of the Dyslexia Center and Vice Chair of the Department of Psychiatry at the University of California, San Francisco. From 2001-2009, he was Professor of Psychiatry and Executive Director and Tsakopoulos-Vismara Chair at the University of California, Davis M.I.N.D. Institute (Medical Investigation of Neurodevelopmental Disorders). Dr. Hendren is Past President of the American Academy of Child and Adolescent Psychiatry (2007-2009). He has published over 100 scientific papers and 4 books and has been listed in “The Best Doctors in America”, each year since it was first published in 1996.
Dr. Hendren took his residency in general psychiatry at the Mayo Graduate School of Medicine, and his child and adolescent psychiatry fellowship at the Yale Child Study Center. He is board certified in General as well as Child and Adolescent Psychiatry.
His current areas of research and publication interests are translational clinical pharmacology and nutritional trials using biomarkers (MRI, measures of inflammation, oxidative stress, immune function and pharmacogenomics) in neurodevelopmental disorders.
Published: 02/26/2014
Robert L. Hendren, D.O., is head of PRONTO Research Lab, a consultant for the STAR Autism Clinic, and Co-Director of the Dyslexia Center and Vice Chair of the Department of Psychiatry at the University of California, San Francisco.
Gene Therapy for Mutations in the IQSEC2 Gene
The IQSEC2 protein is a guanine nucleotide exchange factor for Arf6. Pathogenic variants in the X-linked IQSEC2 gene are associated with drug-resistant epilepsy, severe intellectual disability, and autism. The vast
Towards the Development of a Diagnostic Test for Autism Spectrum Disorder: Data Science Meets Metabolomics
Hear Juergen Hahn, Ph.D., ARI Scientific Advisory Board member, discuss how using machine learning can lead to biomarker discoveries in autism research. Handouts are online HERE
How Genetics is Shaping the Field of Autism Research
Learn about how research on genetic influences is shaping our understanding of autism. About the speaker: M. Pilar Trelles, MD, is a licensed and
Breakthroughs in Understanding roles of Genes and Environment in Autism
About the speaker: Dr. Jonathan Sebat, Director, Beyster Center for Psychiatric Genomics Dr. Sebat leads an interdisciplinary team in the clinical and genomic analysis of
The Low-Hanging Fruit: Exploring Monogenic Syndromes with Elevated Rates of Autism
Dr. Daniel Vogt, Ph.D., explores monogenic syndromes and what they can tell us about the underlying causes of autism. He describes signaling pathways critical in early development, highlighting the electrical nature of
Biomarkers start telling us a story: Autism pathophysiology revisited
This is a joint presentation with the World Autism Organisation. Antonio Persico, MD, a recent ARI Research Grant recipient, explores the role of biomarkers in understanding autism pathophysiology. He